STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 63 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $790,000 | -1.2% | 73,870 | -0.0% | 0.00% | 0.0% |
| Q3 2016 | $800,000 | +79.0% | 73,893 | +11.8% | 0.00% | 0.0% |
| Q2 2016 | $447,000 | +64.3% | 66,093 | +13.1% | 0.00% | – |
| Q1 2016 | $272,000 | -25.9% | 58,417 | +0.5% | 0.00% | – |
| Q4 2015 | $367,000 | -28.3% | 58,127 | +0.3% | 0.00% | -100.0% |
| Q3 2015 | $512,000 | -25.5% | 57,934 | -0.8% | 0.00% | 0.0% |
| Q2 2015 | $687,000 | +10.1% | 58,402 | +35.4% | 0.00% | 0.0% |
| Q1 2015 | $624,000 | +7.8% | 43,138 | +27.1% | 0.00% | 0.0% |
| Q4 2014 | $579,000 | +36.6% | 33,943 | -0.3% | 0.00% | 0.0% |
| Q3 2014 | $424,000 | -13.1% | 34,058 | +2.3% | 0.00% | 0.0% |
| Q2 2014 | $488,000 | -10.8% | 33,289 | +23.9% | 0.00% | 0.0% |
| Q1 2014 | $547,000 | +6.4% | 26,863 | +2.4% | 0.00% | 0.0% |
| Q4 2013 | $514,000 | -56.2% | 26,232 | +1.2% | 0.00% | -50.0% |
| Q3 2013 | $1,174,000 | +106.7% | 25,927 | +8.8% | 0.00% | +100.0% |
| Q2 2013 | $568,000 | – | 23,828 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 475,200 | $6,877,000 | 3.03% |
| Avoro Capital Advisors LLC | 475,000 | $6,873,000 | 2.64% |
| VHCP Management, LLC | 451,400 | $6,532,000 | 1.50% |
| Sio Capital Management, LLC | 140,000 | $2,026,000 | 1.15% |
| Opus Point Partners Management, LLC | 75,000 | $1,085,000 | 0.91% |
| Eventide Asset Management | 620,200 | $8,974,000 | 0.68% |
| Telemetry Investments, L.L.C. | 55,000 | $796,000 | 0.44% |
| Healthcare Value Capital, LLC | 25,000 | $362,000 | 0.40% |
| TFS CAPITAL LLC | 259,916 | $3,761,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 672,562 | $9,732,000 | 0.14% |